Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|11|1399-1409

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.11, 2006-11, pp. : 1399-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

By Medina Miguel   Avila Jesús  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

By MacAulay Katrina   Woodgett James R  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1265-1274

Informa Healthcare

Access to resources Recommend Favorite

Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 281-290

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3

By Robertson Lindsie A.   Kim Anna J.   Werstuck Geoff H.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 39-48

NRC Research Press

Access to resources Recommend Favorite